SALEM INVESTMENT COUNSELORS INC
Position in KRYS — Krystal Biotech, Inc.
CIK 884423
WINSTON-SALEM, NC
Position in KRYS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,858
+$446 QoQ
Shares Held
5
-37.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#396
of 419 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SALEM INVESTMENT COUNSELORS INC holds $2,462,425 across 22 Biotechnology names. KRYS ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
100,000 | $1,782,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
494 | $245,384 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
5,746 | $99,980 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
2,288 | $89,254 | |
| 5 | INCY |
Incyte Corp
|
779 | $88,307 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
2,675 | $45,394 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
1,000 | $32,230 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
535 | $29,178 |
All Filings in KRYS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,858 | 5 | Shares | Sole | 2026-07-14 | |
| 2025-09-30 | $1,412 | 8 | Shares | Sole | 2025-10-07 | |
| No filing history on record for this holder in this stock. | ||||||